Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization.
Zhi-Chun GuMeng-Fei DaiQi WeiYi-Dan YanJian-Yong ZhengGui-Ying WangZheng-Qiang WeiChang-Qing JingYong-Xiang LiDong-Bing ZhouMou-Bin LinXian-Li HeFan LiQian LiuShi-Liang TuZhen-Jun WangAng LiHou-Wen LinHong-Wei YaoZhong-Tao Zhangnull nullPublished in: Pharmacotherapy (2024)
This study offers a comprehensive nationwide evaluation of existing thromboprophylaxis practices in patients after CRC surgery in China. A specialized clinical pathway was developed to address the identified gaps and improve the quality of care. This clinical pathway incorporates explicit, tailored, detailed recommendations for thromboprophylaxis after CRC surgery.
Keyphrases
- minimally invasive
- coronary artery bypass
- healthcare
- venous thromboembolism
- primary care
- quality improvement
- palliative care
- surgical site infection
- end stage renal disease
- direct oral anticoagulants
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- cross sectional
- smoking cessation
- atrial fibrillation
- patient reported outcomes
- pain management
- affordable care act